NCT02472249View on ClinicalTrials.gov

Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions
Hepatocellular Carcinoma
Interventions
RADIATION

CT perfusion

Two dynamic CT perfusion acquisitions of the whole liver will be performed with a 320-detectors CT, prior and after to the norepinephrine injection.

DRUG

Norepinephrine intra-arteriel/hepatic

A small dose (24 ug) of norepinephrine will be injected in the hepatic artery over 10 seconds. The half-life of the drug is 90 seconds..

Trial Locations (1)

M5G 2N2

Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02472249 - Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC | Biotech Hunter | Biotech Hunter